End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.38 USD | 0.00% |
|
0.00% | -27.62% |
06-14 | Zura Bio Presents Data for the Tibulizumab (Zb-106) Program At Eular 2024 | CI |
06-06 | Zura Bio Limited Announces Formation of a Scientific Advisory Board | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.62% | 211M | |
+16.45% | 122B | |
+21.96% | 116B | |
+25.56% | 27.03B | |
-20.05% | 20.36B | |
-16.28% | 15.91B | |
-15.73% | 16.43B | |
-44.35% | 15.6B | |
+63.91% | 14.94B | |
+2.52% | 13.59B |
- Stock Market
- Equities
- ZURA Stock
- News Zura Bio Limited
- Guggenheim Initiates Zura Bio at Buy With $20 Price Target